ATE87316T1 - Von protein ps2 abgeleitete peptide. - Google Patents

Von protein ps2 abgeleitete peptide.

Info

Publication number
ATE87316T1
ATE87316T1 AT88910051T AT88910051T ATE87316T1 AT E87316 T1 ATE87316 T1 AT E87316T1 AT 88910051 T AT88910051 T AT 88910051T AT 88910051 T AT88910051 T AT 88910051T AT E87316 T1 ATE87316 T1 AT E87316T1
Authority
AT
Austria
Prior art keywords
protein
peptides derived
fragments
pathological conditions
polyclonal
Prior art date
Application number
AT88910051T
Other languages
English (en)
Inventor
Pierre Chambon
Marie-Christine Rio
Jean-Pierre Bellocq
Original Assignee
Aderegem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aderegem filed Critical Aderegem
Application granted granted Critical
Publication of ATE87316T1 publication Critical patent/ATE87316T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT88910051T 1987-10-30 1988-10-28 Von protein ps2 abgeleitete peptide. ATE87316T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8715060A FR2622700B1 (fr) 1987-10-30 1987-10-30 Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
EP88910051A EP0345315B1 (de) 1987-10-30 1988-10-28 Von protein ps2 abgeleitete peptide
PCT/FR1988/000531 WO1989003845A1 (fr) 1987-10-30 1988-10-28 Peptides derives de la proteine ps2

Publications (1)

Publication Number Publication Date
ATE87316T1 true ATE87316T1 (de) 1993-04-15

Family

ID=9356339

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88910051T ATE87316T1 (de) 1987-10-30 1988-10-28 Von protein ps2 abgeleitete peptide.

Country Status (6)

Country Link
EP (1) EP0345315B1 (de)
JP (1) JP2648952B2 (de)
AT (1) ATE87316T1 (de)
DE (1) DE3879684T2 (de)
FR (1) FR2622700B1 (de)
WO (1) WO1989003845A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) * 1995-03-24 1995-03-24 Astra Ab New peptides
JP5652809B2 (ja) 2009-03-02 2015-01-14 株式会社ルネッサンス・エナジー・インベストメント 癌組織由来細胞塊およびその調製法
US20130012404A1 (en) * 2010-01-19 2013-01-10 Osaka Prefectural Hospital Organization Culture method, evaluation method and storage method for cancer-tissue-derived cell mass or aggregated cancer cell mass

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE56046T1 (de) * 1983-03-04 1990-09-15 Health Research Inc Monoklonale antikoerper gegen humane brustkarzinomzellen und ihre verwendung in der diagnose und therapie.

Also Published As

Publication number Publication date
DE3879684T2 (de) 1993-08-19
EP0345315A1 (de) 1989-12-13
FR2622700B1 (fr) 1993-08-13
WO1989003845A1 (fr) 1989-05-05
FR2622700A1 (fr) 1989-05-05
EP0345315B1 (de) 1993-03-24
JP2648952B2 (ja) 1997-09-03
JPH02501746A (ja) 1990-06-14
DE3879684D1 (de) 1993-04-29

Similar Documents

Publication Publication Date Title
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
DE69028388D1 (de) Monoklonaler antikörper gegen ein neues humanes tumor assoziiertes antigen
DK296087D0 (da) Peptidmateriale og fremgangsmaade til paavisning af antistoffer til htlv-iii
FI870447A0 (fi) Htlv-iii-hoeljepeptider.
ES556865A0 (es) Un metodo de inmunoensayo.
JPS6434291A (en) Polynucleotide sequence, its production, polypeptide, fragment, antibody, polynucleotide specimen, diagnosis and estimation of malignant disease and examination of presence or absence of factor of malignant disease
SE8700805D0 (sv) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas
ES8900246A1 (es) Un procedimiento para la preparacion de anticuerpos especificos para uno de los miembros de la familia p 2 de proteinas
ATE505202T1 (de) Immunologische methoden zur behandlung von gastrointestinalem krebs
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
DE69032112D1 (de) Verfahren zur Isolierung von fetalen Zytotrophoblastzellen
ATE151882T1 (de) Karzinomverwandtes haptoglobin (hpr)
DE3879684D1 (de) Von protein ps2 abgeleitete peptide.
NO986218D0 (no) FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100
CA2294514A1 (en) Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum
WO1989001153A1 (en) Methods for breast cancer detection
KR870002453A (ko) 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
Devine All cytokeratin assays are not the same
DK0513227T3 (da) Monoklonale antistoffer, der skelner mellem prote iner med nativ og modificeret sekvens
Sheng et al. Electroimmunoblotting of myelin basic protein peptides: a novel approach to the rapid characterisation of antigenic specificities of monoclonal and polyclonal anti-MBP antibodies
ATE281471T1 (de) Antikörper-testbesteck zur bestimmung von amylin
RU94003431A (ru) Способ иммуногистохимической детекции протеинов на гистологических срезах
HUP9902836A2 (hu) Eljárások az S-100 jelű agyi fehérje meghatározására

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee